课题基金 / 基金详情

PATHOGENESIS AND THERAPY OF AUTOIMMUNE THYROID DISEASE

PATHOGENESIS AND THERAPY OF AUTOIMMUNE THYROID DISEASE
自身免疫性甲状腺疾病的发病机制和治疗
批准号:
2137983
负责人:
LESLIE J DE GROOT
金额:
$19.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1980
资助国家:
美国
项目状态:
已结题
起止时间:
1980-07-01 至 1999-04-30

项目摘要

项目成果

LESLIE J DE GROOT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aim of our research program is to understand the causes of autoimmune thyroid disease, the mechanism of the immune response and, if possible, to develop preventative or therapeutic immunomodulatory measures. We will identify dominant and pathogenic epitopes of TSH receptor (hTSH-R), determine genetic factors promoting the disease, determine the relationship of epitope recognition to MHG genotypes, and study potential immunotherapeutic measures in vitro and in vivo in a SCID mouse model. Epitopes will be identified using recombinant antigen and synthetic peptides reacting with PBMG, T cell lines and T cell clones derived from patients with GD and controls. We will study populations, families with a high incidence of GD, especially homozygous HLA-DQA1 *0501 patients, and young individuals in such families in the early phase of disease. To establish biologic importance of the epitopes we will consider 1) differential reactivity comparing patients with GD and controls, 2) concordance of reactivity by PBMC, and derived T cell lines and clones, 3) correlation of epitope recognition with disease and MHC genotype within families, 4) recognition of epitopes in young family members genetically at risk for GD, 5) changes in lymphocyte reactivity following antigen deprivation, and 6) relation of specific epitopes to MHG genes. Epitope reactivity will be analyzed following mutation of the peptide. Peptides which may be able to act as antagonists to the natural epitope, or to induce anergy in T cell lines or clones in vitro will be investigated. We will study, in SCID mice, the ability of T cell lines, reacting to specific epitopes, to reconstitute thyroiditis and produce thyroid stimulating antibodies in animals also xeno- transplanted with isologous thyroid tissue. In this model we can also test peptide antagonists, epitope induced T cell anergy, and induction of tolerance by antigen. Class II MHC genotypes will be determined by a PCR/site specific oligonucleotide methodology in Caucasian populations, Black populations, and Caucasian and Black family groups, to determine linkage of HLA with disease. Since it is clear that HLA associations explain only part of the genetic influence, we will proceed to type, in specific highly informative families, a group of at least eight candidate immune-associated genes for linkage to GD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PATHOGENESIS AND THERAPY OF AUTOIMMUNE THYROID DISEASE
  • 批准号:
    3228266
  • 项目类别:
  • 资助金额:
    $14.4万
  • 财政年份:
    1980
  • 负责人:
    LESLIE J DE GROOT
  • 依托单位:
PATHOGENESIS AND THERAPY OF AUTOIMMUNE THYROID DISEASE
  • 批准号:
    3228267
  • 项目类别:
  • 资助金额:
    $18.49万
  • 财政年份:
    1980
  • 负责人:
    LESLIE J DE GROOT
  • 依托单位:
PATHOGENESIS AND THERAPY OF AUTOIMMUNE THYROID DISEASE
  • 批准号:
    6827756
  • 项目类别:
  • 资助金额:
    $11.45万
  • 财政年份:
    1980
  • 负责人:
    LESLIE J DE GROOT
  • 依托单位:
PATHOGENSIS AND THERAPY OF AUTOIMMUNE THYROID DISEASE
  • 批准号:
    6040714
  • 项目类别:
  • 资助金额:
    $23.77万
  • 财政年份:
    1980
  • 负责人:
    LESLIE J DE GROOT
  • 依托单位:
海外基金